242 related articles for article (PubMed ID: 18157138)
21. Mixed chimeric hematopoietic stem cell transplant reverses the disease phenotype in canine leukocyte adhesion deficiency.
Creevy KE; Bauer TR; Tuschong LM; Embree LJ; Silverstone AM; Bacher JD; Romines C; Garnier J; Thomas ML; Colenda L; Hickstein DD
Vet Immunol Immunopathol; 2003 Oct; 95(3-4):113-21. PubMed ID: 12963272
[TBL] [Abstract][Full Text] [Related]
22. Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors.
Vassilopoulos G; Trobridge G; Josephson NC; Russell DW
Blood; 2001 Aug; 98(3):604-9. PubMed ID: 11468157
[TBL] [Abstract][Full Text] [Related]
23. Retargeted Foamy Virus Vectors Integrate Less Frequently Near Proto-oncogenes.
Hocum JD; Linde I; Rae DT; Collins CP; Matern LK; Trobridge GD
Sci Rep; 2016 Nov; 6():36610. PubMed ID: 27812034
[TBL] [Abstract][Full Text] [Related]
24. Foamy virus vector integration sites in normal human cells.
Trobridge GD; Miller DG; Jacobs MA; Allen JM; Kiem HP; Kaul R; Russell DW
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1498-503. PubMed ID: 16428288
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type I.
Leon-Rico D; Aldea M; Sanchez-Baltasar R; Mesa-Nuñez C; Record J; Burns SO; Santilli G; Thrasher AJ; Bueren JA; Almarza E
Hum Gene Ther; 2016 Sep; 27(9):668-78. PubMed ID: 27056660
[TBL] [Abstract][Full Text] [Related]
26. Very low levels of donor CD18+ neutrophils following allogeneic hematopoietic stem cell transplantation reverse the disease phenotype in canine leukocyte adhesion deficiency.
Bauer TR; Creevy KE; Gu YC; Tuschong LM; Donahue RE; Metzger ME; Embree LJ; Burkholder T; Bacher JD; Romines C; Thomas ML; Colenda L; Hickstein DD
Blood; 2004 May; 103(9):3582-9. PubMed ID: 14715622
[TBL] [Abstract][Full Text] [Related]
27. Progress and prospects: foamy virus vectors enter a new age.
Erlwein O; McClure MO
Gene Ther; 2010 Dec; 17(12):1423-9. PubMed ID: 20631802
[TBL] [Abstract][Full Text] [Related]
28. Efficiency of different fragment lengths of the ubiquitous chromatin opening element HNRPA2B1-CBX3 in driving human CD18 gene expression within self-inactivating lentiviral vectors for gene therapy applications.
Gopinath C; Chodisetty S; Ghosh A; Nelson EJR
Gene; 2019 Aug; 710():265-272. PubMed ID: 31200085
[TBL] [Abstract][Full Text] [Related]
29. Development of foamy virus vectors.
Vassilopoulos G; Josephson NC; Trobridge G
Methods Mol Med; 2003; 76():545-64. PubMed ID: 12526184
[No Abstract] [Full Text] [Related]
30. A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency.
Kijas JM; Bauer TR; Gäfvert S; Marklund S; Trowald-Wigh G; Johannisson A; Hedhammar A; Binns M; Juneja RK; Hickstein DD; Andersson L
Genomics; 1999 Oct; 61(1):101-7. PubMed ID: 10512685
[TBL] [Abstract][Full Text] [Related]
31. The usefulness of a perfect parasite.
Vassilopoulos G; Rethwilm A
Gene Ther; 2008 Oct; 15(19):1299-1301. PubMed ID: 18802996
[No Abstract] [Full Text] [Related]
32. Leukocyte adhesion deficiency in children and Irish setter dogs.
Bauer TR; Gu YC; Creevy KE; Tuschong LM; Embree L; Holland SM; Sokolic RA; Hickstein DD
Pediatr Res; 2004 Mar; 55(3):363-7. PubMed ID: 14711903
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the in vivo safety of insulated foamy viral vectors.
Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
[TBL] [Abstract][Full Text] [Related]
34. Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors.
Josephson NC; Vassilopoulos G; Trobridge GD; Priestley GV; Wood BL; Papayannopoulou T; Russell DW
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8295-300. PubMed ID: 12060773
[TBL] [Abstract][Full Text] [Related]
35. Intravenous injection of a foamy virus vector to correct canine SCID-X1.
Burtner CR; Beard BC; Kennedy DR; Wohlfahrt ME; Adair JE; Trobridge GD; Scharenberg AM; Torgerson TR; Rawlings DJ; Felsburg PJ; Kiem HP
Blood; 2014 Jun; 123(23):3578-84. PubMed ID: 24642749
[TBL] [Abstract][Full Text] [Related]
36. Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency.
Malech HL; Hickstein DD
Curr Opin Hematol; 2007 Jan; 14(1):29-36. PubMed ID: 17133097
[TBL] [Abstract][Full Text] [Related]
37. In-Vivo Gene Therapy with Foamy Virus Vectors.
Rajawat YS; Humbert O; Kiem HP
Viruses; 2019 Nov; 11(12):. PubMed ID: 31771194
[TBL] [Abstract][Full Text] [Related]
38. Foamy virus vectors.
Mergia A; Heinkelein M
Curr Top Microbiol Immunol; 2003; 277():131-59. PubMed ID: 12908771
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.
Everson EM; Hocum JD; Trobridge GD
J Gene Med; 2018 Jul; 20(7-8):e3028. PubMed ID: 29935087
[TBL] [Abstract][Full Text] [Related]
40. Transduction of hematopoietic cells by foamy virus vectors.
Hirata RK; Miller AD; Andrews RG; Russell DW
Blood; 1996 Nov; 88(9):3654-61. PubMed ID: 8896436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
